Drug Control Authority Statement on Cardiac Safety of Rosiglitazone (Avandia)

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Date : 07 July 2007

Description : Kenyataan Pihak Berkuasa Kawalan Dadah berhubung dengan keselamatan kardiak dengan penggunaan ubat rosiglitazone (Avandia)

avandia

Click here to download (22KB icon pdf)

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Monday 17 June 2019, 16:18:24.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language